Senju Pharmaceutical Co. v. Akorn, Inc.

 
DOCKET NO.
OP. BELOW
SUBJECT
Patent

Question(s) Presented

1. “Whether 35 U.S.C. § 144’s directive that the Federal Circuit “shall issue . . . its mandate and opinion” in all appeals from the Patent and Trademark Office precludes the Federal Circuit from resolving such appeals through a Rule 36 judgment of affirmance without opinion.” 2. “Whether, under this Court’s decisions in Graham v. John Deere Co., 383 U.S. 1 (1966), and KSR International Co. v. Teleflex Inc., 550 U.S. 398 (2007), the Patent Trial and Appeal Board must consider all relevant evidence, including any objective indicia of non-obviousness, when assessing whether a patent is invalid under 35 U.S.C. § 103.”

Date
Proceedings and Orders
March 4, 2019
Application (18A892) granted by The Chief Justice extending the time to file until April 10, 2019.
March 22, 2019
Application (18A892) to extend further the time from April 10, 2019 to May 10, 2019, submitted to The Chief Justice.
March 26, 2019
Application (18A892) granted by The Chief Justice extending the time to file until May 10, 2019.
June 26, 2019
DISTRIBUTED for Conference of 10/1/2019.
October 7, 2019
Petition DENIED.